J. Christopher Naftzger - Net Worth and Insider Trading
J. Christopher Naftzger Net Worth
The estimated net worth of J. Christopher Naftzger is at least $0 dollars as of 2024-05-04. J. Christopher Naftzger is the General Counsel and Corp Sec of Nabriva Therapeutics PLC and owns about 280 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in J. Christopher Naftzger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that J. Christopher Naftzger has not made any transactions after 2021-12-27 and currently still holds the listed stock(s).
Transaction Summary of J. Christopher Naftzger
J. Christopher Naftzger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J. Christopher Naftzger owns 2 companies in total, including Nabriva Therapeutics PLC (NBRVF) , and Arbutus Biopharma Corp (ABUS) .
Click here to see the complete history of J. Christopher Naftzger’s form 4 insider trades.
Insider Ownership Summary of J. Christopher Naftzger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBRVF | Nabriva Therapeutics PLC | 2021-12-27 | General Counsel and Corp Sec |
| ABUS | Arbutus Biopharma Corp | 2023-07-10 | General Counsel and CCO |
J. Christopher Naftzger Latest Holdings Summary
J. Christopher Naftzger currently owns a total of 1 stock. J. Christopher Naftzger owns 280 shares of Nabriva Therapeutics PLC (NBRVF) as of December 27, 2021, with a value of $0.
Latest Holdings of J. Christopher Naftzger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBRVF | Nabriva Therapeutics PLC | 2021-12-27 | 280 | 0.00 | 0 |
Holding Weightings of J. Christopher Naftzger
J. Christopher Naftzger Form 4 Trading Tracker
According to the SEC Form 4 filings, J. Christopher Naftzger has made a total of 1 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Nabriva Therapeutics PLC is the acquisition of 280 shares on December 27, 2021, which cost J. Christopher Naftzger around $4,130.
Insider Trading History of J. Christopher Naftzger
- 1
J. Christopher Naftzger Trading Performance
GuruFocus tracks the stock performance after each of J. Christopher Naftzger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J. Christopher Naftzger is -16.12%. GuruFocus also compares J. Christopher Naftzger's trading performance to market benchmark return within the same time period. The performance of stocks bought by J. Christopher Naftzger within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J. Christopher Naftzger's insider trading performs compared to the benchmark.
Performance of J. Christopher Naftzger
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22.59 | | | | | |
| Relative Return to S&P 500(%) | -12.89 | | | | | |
J. Christopher Naftzger Ownership Network
J. Christopher Naftzger Owned Company Details
What does Nabriva Therapeutics PLC do?
Who are the key executives at Nabriva Therapeutics PLC?
J. Christopher Naftzger is the General Counsel and Corp Sec of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .
Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nabriva Therapeutics PLC Insider Transactions
J. Christopher Naftzger Mailing Address
Above is the net worth, insider trading, and ownership report for J. Christopher Naftzger. You might contact J. Christopher Naftzger via mailing address: 633 Lowther Road, Lewisberry Pa 17339.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
